Edition:
India

People: Genprex Inc (GNPX.OQ)

GNPX.OQ on NASDAQ Stock Exchange Capital Market

1.08USD
15 Jul 2019
Change (% chg)

-- (--)
Prev Close
$1.08
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
10,155
52-wk High
$7.88
52-wk Low
$0.95

Varner, J. Rodney 

Mr. J. Rodney Varner is Chairman of the Board, Chief Executive Officer, Secretary of the Company. He is a co-founder of Genprex and has served as our President, Chief Executive Officer and Secretary, and as a member of our board of directors and as Chairman of our board of directors since August 2012. Mr. Varner served as a partner of the law firm Wilson & Varner, LLP, since 1991. Mr. Varner has more than thirty-five years of legal experience with large and small law firms, and as outside general counsel of a Nasdaq listed company. Mr. Varner has represented for-profit and non-profit companies at the board of directors or senior management levels in a wide variety of contractual, business, tax and securities matters, including technology transfers, licensing, collaboration and research agreements, clinical trial contracts, pharmaceutical and biologics manufacturing and process development contracts, state and federal grants, including NIH and SBA grants, corporate governance and fiduciary issues, and real estate matters. Mr. Varner served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. Mr. Varner is a member of the State Bar of Texas and has been admitted to practice before the United States Court of Appeals for the Fifth Circuit and the United States Tax Court. He is a registered securities representative and founder of a company that is a licensed securities broker-dealer. Mr. Varner received his BBA, with high honors, from Texas A&M University and his J.D. from The University of Texas School of Law.

Basic Compensation

Total Annual Compensation, USD 75,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 793,202
Fiscal Year Total, USD 868,202

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --